메뉴 건너뛰기
International Journal of Clinical Oncology
Volumn 12, Issue 5, 2007, Pages 385-387
Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma
Author keywords

Gemcitabine; Hemolytic uremic syndrome; HUS
Indexed keywords

ALPHA INTERFERON; BLEOMYCIN; CA 125 ANTIGEN; CARBOPLATIN; CISPLATIN; CYTARABINE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; MITOMYCIN C; PACLITAXEL; PENTOSTATIN; TAMOXIFEN; TOPOTECAN;
EID: 35348923520     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-007-0676-8     Document Type: Article
Times cited : (7)
References (9)
  • 1
    • 0023378146 scopus 로고
    • Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents
    • AJ Murgo 1987 Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents Semin Hematol 24 161 177
    • (1987) Semin Hematol , vol.24 , pp. 161-177
    • Murgo, A.J.1
  • 2
    • 27244450452 scopus 로고    scopus 로고
    • Hemolytic-uremic syndrome associated with gemcitabine: A case report and review of literature
    • MW Saif PJ McGee 2005 Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature JOP 6 369 374
    • (2005) JOP , vol.6 , pp. 369-374
    • Saif, M.W.1    McGee, P.J.2
  • 4
    • 0032822792 scopus 로고    scopus 로고
    • Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine
    • M Gross C Hiesse F Kriaa F Goldwasser 1999 Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine Anticancer Drugs 10 533 536
    • (1999) Anticancer Drugs , vol.10 , pp. 533-536
    • Gross, M.1    Hiesse, C.2    Kriaa, F.3    Goldwasser, F.4
  • 5
    • 0028292341 scopus 로고
    • Phase II trial of gemcitabine (2,2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas
    • ES Casper MR Green DP Kelsen 1994 Phase II trial of gemcitabine (2,2′-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas Invest New Drugs 12 29 34
    • (1994) Invest New Drugs , vol.12 , pp. 29-34
    • Casper, E.S.1    Green, M.R.2    Kelsen, D.P.3
  • 6
    • 0033134916 scopus 로고    scopus 로고
    • A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy
    • MC Fung AM Storniolo B Nguyen 1999 A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy Cancer 85 2023 2032
    • (1999) Cancer , vol.85 , pp. 2023-2032
    • Fung, M.C.1    Storniolo, A.M.2    Nguyen, B.3
  • 7
    • 2642566772 scopus 로고    scopus 로고
    • Gemcitabine-associated thrombotic microangiopathy
    • BD Humphreys JP Sharman JM Henderson 2004 Gemcitabine-associated thrombotic microangiopathy Cancer 100 2664 2670
    • (2004) Cancer , vol.100 , pp. 2664-2670
    • Humphreys, B.D.1    Sharman, J.P.2    Henderson, J.M.3
  • 8
    • 11844291977 scopus 로고    scopus 로고
    • Hemolytic uremic syndrome following prolonged gemcitabine therapy: Report of four cases from a single institution
    • S Muller P Schutt P Bojko 2005 Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution Ann Hematol 84 110 114
    • (2005) Ann Hematol , vol.84 , pp. 110-114
    • Muller, S.1    Schutt, P.2    Bojko, P.3
  • 9
    • 15544362071 scopus 로고    scopus 로고
    • Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin
    • SN Lewin DG Mutch BP Whitcomb 2005 Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin Gynecol Oncol 97 228 233
    • (2005) Gynecol Oncol , vol.97 , pp. 228-233
    • Lewin, S.N.1    Mutch, D.G.2    Whitcomb, B.P.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.